SSA
VHAQ.RT

Schonfeld Strategic Advisors’s Viveon Health Acquisition Corp. Rights, each exchangeable into one-twentieth of a share of Common Stock VHAQ.RT Stock Holding History

Schonfeld Strategic Advisors’s Portfolio VHAQ.RT Stock Details VHAQ.RT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-20,000
Closed -$1.05K – 2524
2023
Q4 		$1.05K Buy
20,000
+9,800
+96% +$554 ﹤0.01% 1766
2023
Q3 		$591 Buy
+10,200
New +$655 ﹤0.01% 1697

Other funds holding VHAQ.RT

SIA
SkyView Investment Advisors Shrewsbury, New Jersey $743M AUM 17.91% 1-Year Est. Return
RCM
Rivernorth Capital Management West Palm Beach, Florida $2B AUM 0.66% 1-Year Est. Return

Schonfeld Strategic Advisors's VHAQ.RT Position: Q1 2024 in Review

Schonfeld Strategic Advisors sold out of Viveon Health Acquisition Corp. Rights, each exchangeable into one-twentieth of a share of Common Stock (VHAQ.RT) in Q1 2024, closing a stake of 20,000 shares — an estimated $1.05K sold.

Schonfeld Strategic Advisors first reported a position in VHAQ.RT in Q3 2023 and held it in 2 quarters. The position peaked at $1.05K in Q4 2023. 5 funds tracked by Wall St. Rank hold VHAQ.RT as of Q1 2024.

  • Schonfeld Strategic Advisors reported no remaining Viveon Health Acquisition Corp. Rights, each exchangeable into one-twentieth of a share of Common Stock position as of Q1 2024 after selling out during the quarter.
  • Schonfeld Strategic Advisors sold 20,000 Viveon Health Acquisition Corp. Rights, each exchangeable into one-twentieth of a share of Common Stock shares in Q1 2024, an estimated $1.05K.
  • Schonfeld Strategic Advisors first reported a position in Viveon Health Acquisition Corp. Rights, each exchangeable into one-twentieth of a share of Common Stock in Q3 2023 and held it in 2 quarters.
  • Schonfeld Strategic Advisors's Viveon Health Acquisition Corp. Rights, each exchangeable into one-twentieth of a share of Common Stock position peaked at $1.05K in Q4 2023.
  • 5 funds tracked by Wall St. Rank held Viveon Health Acquisition Corp. Rights, each exchangeable into one-twentieth of a share of Common Stock as of Q1 2024.

Based on Schonfeld Strategic Advisors's 13F filing for Q1 2024, filed 15 May 2024.